CY1116662T1 - Μεθοδοι χρησης αναστολεων alk - Google Patents
Μεθοδοι χρησης αναστολεων alkInfo
- Publication number
- CY1116662T1 CY1116662T1 CY20151100758T CY151100758T CY1116662T1 CY 1116662 T1 CY1116662 T1 CY 1116662T1 CY 20151100758 T CY20151100758 T CY 20151100758T CY 151100758 T CY151100758 T CY 151100758T CY 1116662 T1 CY1116662 T1 CY 1116662T1
- Authority
- CY
- Cyprus
- Prior art keywords
- methods
- alk
- use alk
- eml4
- crisotinib
- Prior art date
Links
- 206010041067 Small cell lung cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000000587 small cell lung carcinoma Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161438878P | 2011-02-02 | 2011-02-02 | |
| EP12703670.5A EP2670401B1 (en) | 2011-02-02 | 2012-02-02 | Methods of using alk inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1116662T1 true CY1116662T1 (el) | 2017-03-15 |
Family
ID=45582065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20151100758T CY1116662T1 (el) | 2011-02-02 | 2015-08-28 | Μεθοδοι χρησης αναστολεων alk |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US8703787B2 (OSRAM) |
| EP (1) | EP2670401B1 (OSRAM) |
| JP (1) | JP5837095B2 (OSRAM) |
| KR (1) | KR101521861B1 (OSRAM) |
| CN (1) | CN103458881B (OSRAM) |
| AU (1) | AU2012212142B2 (OSRAM) |
| BR (1) | BR112013019643B1 (OSRAM) |
| CA (1) | CA2824092C (OSRAM) |
| CY (1) | CY1116662T1 (OSRAM) |
| DK (1) | DK2670401T3 (OSRAM) |
| EA (1) | EA023404B1 (OSRAM) |
| ES (1) | ES2543567T3 (OSRAM) |
| HR (1) | HRP20150946T1 (OSRAM) |
| HU (1) | HUE025395T2 (OSRAM) |
| ME (1) | ME02200B (OSRAM) |
| MX (1) | MX2013008791A (OSRAM) |
| PL (1) | PL2670401T3 (OSRAM) |
| PT (1) | PT2670401E (OSRAM) |
| RS (1) | RS54189B1 (OSRAM) |
| SI (1) | SI2670401T1 (OSRAM) |
| SM (1) | SMT201500300B (OSRAM) |
| WO (1) | WO2012106540A1 (OSRAM) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2890006C (en) | 2012-11-06 | 2021-11-23 | Shanghai Fochon Pharmaceutical Co Ltd | Alk kinase inhibitors |
| KR20150081344A (ko) * | 2012-11-07 | 2015-07-13 | 노파르티스 아게 | 조합 요법 |
| CN104109149B (zh) | 2013-04-22 | 2018-09-28 | 苏州泽璟生物制药有限公司 | 氘代的二氨基嘧啶化合物以及包含该化合物的药物组合物 |
| ITMI20131124A1 (it) * | 2013-07-04 | 2015-01-05 | Univ Milano Bicocca | 2-acilamminotiazoli per il trattamento del cancro |
| JP6510510B2 (ja) * | 2013-07-11 | 2019-05-08 | ベータ ファーマシューティカルズ カンパニー リミテッド | プロテインチロシンキナーゼモジュレーター及び使用方法 |
| ES2674361T3 (es) * | 2013-08-28 | 2018-06-29 | Novartis Ag | Combinación de un inhibidor de ALK y un inhibidor de CDK para el tratamiento de enfermedades celulares proliferativas |
| CN104672214B (zh) * | 2013-12-03 | 2019-04-12 | 上海翰森生物医药科技有限公司 | 具有alk抑制活性的化合物及其制备与用途 |
| KR20160100975A (ko) * | 2013-12-23 | 2016-08-24 | 노파르티스 아게 | 제약 조합물 |
| CN104876914B (zh) * | 2014-02-28 | 2017-04-19 | 山东轩竹医药科技有限公司 | 嘧啶衍生物类间变性淋巴瘤激酶抑制剂 |
| KR101656382B1 (ko) * | 2014-02-28 | 2016-09-09 | 한국화학연구원 | 피리미딘-2,4-디아민 유도체 및 이를 유효성분으로 함유하는 항암용 약학적 조성물 |
| JP6622726B2 (ja) * | 2014-06-17 | 2019-12-18 | コリア リサーチ インスティチュート オブ ケミカル テクノロジーＫｏｒｅａ Ｒｅｓｅａｒｃｈ Ｉｎｓｔｉｔｕｔｅ Ｏｆ Ｃｈｅｍｉｃａｌ Ｔｅｃｈｎｏｌｏｇｙ | ピリミジン‐２，４‐ジアミン誘導体及びそれを有効成分として含有する抗癌用医薬組成物 |
| CN105524045B (zh) * | 2014-10-22 | 2020-04-10 | 山东轩竹医药科技有限公司 | 四环类间变性淋巴瘤激酶抑制剂 |
| CN106146525B (zh) * | 2015-04-10 | 2018-11-02 | 山东轩竹医药科技有限公司 | 三并环类间变性淋巴瘤激酶抑制剂 |
| CN111440189B (zh) | 2015-04-24 | 2022-08-09 | 广州再极医药科技有限公司 | 稠环嘧啶氨基衍生物、其制备方法、中间体、药物组合物及应用 |
| CN106699743B (zh) | 2015-11-05 | 2020-06-12 | 湖北生物医药产业技术研究院有限公司 | 嘧啶类衍生物及其用途 |
| CN106220608B (zh) * | 2016-07-25 | 2018-11-27 | 安润医药科技（苏州）有限公司 | 二苯氨基嘧啶及三嗪化合物、其药用组合物及用途 |
| CN107698603B (zh) * | 2016-08-09 | 2022-04-08 | 南京红云生物科技有限公司 | 噻吩并嘧啶类化合物、其制备方法、药用组合物及其应用 |
| SG11201901251SA (en) * | 2016-08-29 | 2019-03-28 | Univ Michigan Regents | Aminopyrimidines as alk inhibitors |
| CN111484484B (zh) * | 2020-04-13 | 2021-11-23 | 沈阳药科大学 | 含芳杂环的2,4-二芳氨基嘧啶衍生物及其制备与应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9301192D0 (en) | 1993-06-09 | 1993-06-09 | Trott Francis W | Flower shaped mechanised table |
| GB0305929D0 (en) * | 2003-03-14 | 2003-04-23 | Novartis Ag | Organic compounds |
| TWI378923B (en) * | 2003-08-15 | 2012-12-11 | Novartis Ag | Pyrimidine derivatives |
| GB0419161D0 (en) * | 2004-08-27 | 2004-09-29 | Novartis Ag | Organic compounds |
| ES2533575T3 (es) | 2006-07-10 | 2015-04-13 | Goji Limited | Método y sistema para calentamiento con microondas de multifrecuencia |
| CA2598893C (en) * | 2006-10-11 | 2012-04-10 | Astellas Pharma Inc. | Eml4-alk fusion gene |
| BRPI0722383A2 (pt) * | 2006-12-08 | 2012-06-05 | Irm Llc | compostos inibidores de proteìna quinase, composições contendo os mesmos bem como seus usos |
| WO2008073687A2 (en) | 2006-12-08 | 2008-06-19 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
| US8592432B2 (en) * | 2008-04-07 | 2013-11-26 | Bei Chen | Compounds and compositions as protein kinase inhibitors |
-
2012
- 2012-02-02 HU HUE12703670A patent/HUE025395T2/en unknown
- 2012-02-02 MX MX2013008791A patent/MX2013008791A/es unknown
- 2012-02-02 CN CN201280007465.9A patent/CN103458881B/zh active Active
- 2012-02-02 JP JP2013552637A patent/JP5837095B2/ja active Active
- 2012-02-02 DK DK12703670.5T patent/DK2670401T3/en active
- 2012-02-02 CA CA2824092A patent/CA2824092C/en active Active
- 2012-02-02 EP EP12703670.5A patent/EP2670401B1/en active Active
- 2012-02-02 ME MEP-2015-127A patent/ME02200B/me unknown
- 2012-02-02 SI SI201230285T patent/SI2670401T1/sl unknown
- 2012-02-02 BR BR112013019643-2A patent/BR112013019643B1/pt active IP Right Grant
- 2012-02-02 WO PCT/US2012/023669 patent/WO2012106540A1/en not_active Ceased
- 2012-02-02 PT PT127036705T patent/PT2670401E/pt unknown
- 2012-02-02 US US13/981,046 patent/US8703787B2/en active Active
- 2012-02-02 KR KR1020137023001A patent/KR101521861B1/ko active Active
- 2012-02-02 HR HRP20150946TT patent/HRP20150946T1/hr unknown
- 2012-02-02 PL PL12703670T patent/PL2670401T3/pl unknown
- 2012-02-02 AU AU2012212142A patent/AU2012212142B2/en active Active
- 2012-02-02 EA EA201391114A patent/EA023404B1/ru not_active IP Right Cessation
- 2012-02-02 RS RS20150563A patent/RS54189B1/sr unknown
- 2012-02-02 ES ES12703670.5T patent/ES2543567T3/es active Active
-
2015
- 2015-08-28 CY CY20151100758T patent/CY1116662T1/el unknown
- 2015-11-30 SM SM201500300T patent/SMT201500300B/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2824092A1 (en) | 2012-08-09 |
| CN103458881A (zh) | 2013-12-18 |
| AU2012212142B2 (en) | 2015-09-24 |
| KR101521861B1 (ko) | 2015-05-21 |
| HUE025395T2 (en) | 2016-02-29 |
| ME02200B (me) | 2016-02-20 |
| SMT201500300B (it) | 2016-01-08 |
| WO2012106540A1 (en) | 2012-08-09 |
| PL2670401T3 (pl) | 2015-11-30 |
| JP2014504646A (ja) | 2014-02-24 |
| CN103458881B (zh) | 2015-08-12 |
| JP5837095B2 (ja) | 2015-12-24 |
| HRP20150946T1 (hr) | 2015-10-09 |
| AU2012212142A1 (en) | 2013-08-15 |
| CA2824092C (en) | 2020-06-30 |
| US20130296357A1 (en) | 2013-11-07 |
| EP2670401B1 (en) | 2015-06-10 |
| ES2543567T3 (es) | 2015-08-20 |
| BR112013019643A2 (pt) | 2016-10-04 |
| EA023404B1 (ru) | 2016-05-31 |
| EP2670401A1 (en) | 2013-12-11 |
| DK2670401T3 (en) | 2015-09-07 |
| SI2670401T1 (sl) | 2015-10-30 |
| EA201391114A1 (ru) | 2013-12-30 |
| MX2013008791A (es) | 2013-10-07 |
| RS54189B1 (sr) | 2015-12-31 |
| US8703787B2 (en) | 2014-04-22 |
| KR20130121174A (ko) | 2013-11-05 |
| BR112013019643B1 (pt) | 2022-04-19 |
| PT2670401E (pt) | 2015-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1121706T1 (el) | Ενωσεις υποκατασταθεισες διυδροϊσοκινολινονης | |
| CY1122707T1 (el) | Ετεροκυκλικοι αναστολεις γλουταμινασης | |
| CY1118129T1 (el) | 5-αλκυνυλ-πυριμιδινες | |
| PH12014502697B1 (en) | New diazaspirocycloalkane and azaspirocycloalkane | |
| MX358376B (es) | Nuevos derivados dihidroquinolina-2-ona. | |
| CY1119531T1 (el) | Ενωσεις και συνθεσεις για την ρυθμιση της δραστηριοτητας toy egfr | |
| MX2015007097A (es) | Nuevas fenil-piridinas/pirazinas bi-anulares para el tratamiento de cancer. | |
| CY1115945T1 (el) | Παραγωγα πυραζολοκινολινονης, η παρασκευη τους και η θεραπευτικη τους χρηση | |
| EA201401054A1 (ru) | N-циклиламиды в качестве нематоцидов | |
| IN2015DN00960A (OSRAM) | ||
| CY1117105T1 (el) | Ενωσεις πυριδαζινονης και χρηση τους ως αναστολεις του daao | |
| MX2014014531A (es) | Derivados de aminoquinazolina y piridopirimidina. | |
| UA111305C2 (uk) | Конденсовані лактами арилу та гетероарилу | |
| CY1120355T1 (el) | Αναστολεις toy iap | |
| EA201391114A1 (ru) | Способы использования alk-ингибиторов | |
| MX2015001099A (es) | Nuevos derivados biciclicos de piridina. | |
| MX2015001720A (es) | Hetero-azepinonas sustituidas. | |
| PH12014500814A1 (en) | New aryl-quinoline derivatives | |
| MX2012008141A (es) | Compuestos y metodos. | |
| CY1117843T1 (el) | Νεα παραγωγα θειενοπυριμιδινης, διεργασιες για την παρασκευη αυτων και θεραπευτικες χρησεις αυτων | |
| CY1120133T1 (el) | Πυριδαζινονες ως αναστολεις ενζυμου daao | |
| MX2015016332A (es) | Inhibidores de alk biciclicos fusionados. | |
| EA201590656A1 (ru) | Азаиндолины | |
| MX342311B (es) | Nuevos compuestos de azaespirodecanona como inhibidores de lipasa sensible a hormonas (hsl). | |
| EA201401045A1 (ru) | Соединения для лечения заболеваний, связанных с ишемией-реперфузией |